XOMA Royalty Corporation (XOMA)
(Real Time Quote from BATS)
$25.86 USD
-0.56 (-2.12%)
Updated Aug 7, 2025 03:30 PM ET
After-Market: $26.13 +0.27 (1.04%) 4:06 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, XOMA Royalty Corporation has a market cap of $316.17M, which represents its share price of $26.42 multiplied by its outstanding shares number of 11.97M. As a small-cap company, XOMA's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
XOMA 25.86 -0.56(-2.12%)
Will XOMA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for XOMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XOMA
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
XOMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates
Stoke Therapeutics (STOK) Soars 12.0%: Is Further Upside Left in the Stock?
What Makes XOMA Royalty (XOMA) a New Buy Stock
Other News for XOMA
I'm Staying Neutral On XOMA Royalty After The LAVA And HilleVax Deals
XOMA Royalty Breaks Above 200-Day Moving Average - Bullish for XOMA
XOMA Royalty to acquire cancer drug developer LAVA Therapeutics
XOMA Royalty (XOMA) to Acquire HilleVax (HLVX) in Cash Deal
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1. ...